Yüklüyor......
Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
Treatment with immunotherapy has made a significant impact in the outcomes for those individuals diagnosed with metastatic non-small cell lung cancer (NSCLC) and its use is currently an established treatment modality. In light of recent advances in immunotherapy, improved survival, particularly for...
Kaydedildi:
| Yayımlandı: | J Thorac Dis |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5861264/ https://ncbi.nlm.nih.gov/pubmed/29593888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.01.141 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|